Jun 22, 2021 / 06:00PM GMT
Elliot Wilbur - Raymond James Financial - Analyst
Good afternoon. Welcome to the Amphastar Pharmaceuticals presentation at Raymond James annual Health and Human Innovation Conference. Pleased to welcome the Company here with us this afternoon. Representing the management, we have Dan Dischner, who heads the Company's Corporate Communication effort. We are also joined by Bill Peters, Amphastar's CFO; and Jacob Liawatidewi, who is the Company's Vice President of Sales and Marketing.
For those not familiar with the Amphastar story, Amphastar is a specialty generics company focused on injectable and inhalation products, with development capabilities targeting complex specialty generics, biosimilars, and 505(b)(2)-branded products. With that, I'm going to turn the forum over to Dan Dischner, who is going to provide us with an update, and then we will move into Q&A session. Dan?
Dan Dischner - Amphastar Pharmaceuticals, Inc. - VP of Corporate Communications
Yes. Good morning or afternoon, depending on where you are. Before I begin, I want to thank Raymond
Amphastar Pharmaceuticals Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers